Skip to content
HowShorted

Cardiff Oncology, Inc. short interest in 2020

In 2020, Cardiff Oncology, Inc.'s disclosed short interest ran from 8.11% of shares outstanding on 15 Jul 2020 to 13.31% on 31 Dec 2020, a change of +5.20 percentage points. The year's high was 13.31% on 31 Dec 2020 and its low 2.91% on 14 Aug 2020, averaging 6.15% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.65 days on 31 Dec 2020. Full history: Cardiff Oncology, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Cardiff Oncology, Inc. in 2020

2020 in figures

Start of year
8.11% (15 Jul 2020)
End of year
13.31% (31 Dec 2020)
Change
+5.20 pp
High
13.31% (31 Dec 2020)
Low
2.91% (14 Aug 2020)
Average
6.15%
Highest days to cover
3.65 (31 Dec 2020)
SEC filings marked
8

Every report in 2020

Cardiff Oncology, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jul 20208.11%1.5210-K filed, results (8-K), 10-Q filed, results (8-K)
31 Jul 20203.63%1.23
14 Aug 20202.91%1.0010-Q filed, results (8-K)
31 Aug 20204.18%1.37
15 Sep 20204.10%1.40
30 Oct 20206.55%2.95
13 Nov 20207.11%3.3310-Q filed, results (8-K)
30 Nov 20205.89%2.81
15 Dec 20205.67%2.07
31 Dec 202013.31%3.65

See also: Cardiff Oncology, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.